What is the recommended dose of Bactrim DS (Sulfamethoxazole/Trimethoprim) for folliculitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Recommended Bactrim DS Dosage for Folliculitis

For folliculitis treatment, the recommended dose of Bactrim DS (Sulfamethoxazole/Trimethoprim) is 1-2 double-strength tablets (800mg/160mg per tablet) twice daily for 7-10 days. 1

Dosing Guidelines

  • Bactrim DS standard adult dosage for skin and soft tissue infections (including folliculitis): 1-2 double-strength tablets (800mg/160mg) twice daily 1
  • Pediatric dosage: 8-12 mg/kg/day (based on trimethoprim component) in either 4 divided doses IV or 2 divided doses orally 1
  • Duration of therapy is typically 7-10 days, depending on clinical response 1

Efficacy and Clinical Considerations

  • Trimethoprim-sulfamethoxazole (TMP-SMX) is particularly effective against community-acquired methicillin-resistant Staphylococcus aureus (CA-MRSA), which is a common cause of folliculitis 1
  • While TMP-SMX has good activity against aerobes (including Staphylococcus), it has relatively poor activity against anaerobes 1
  • For severe or extensive folliculitis (multiple sites, rapid progression, systemic symptoms), consider inpatient management and possibly IV antibiotics 1

Special Populations and Dose Adjustments

  • Renal impairment requires dose adjustment:
    • Creatinine clearance 15-30 mL/min: Reduce dose by 50% 1
    • Creatinine clearance <15 mL/min: Not recommended 1
  • TMP-SMX is pregnancy category C/D and not recommended for women in the third trimester of pregnancy 1
  • Not recommended for children under 2 months of age 1

Potential Adverse Effects

  • Common side effects include gastrointestinal disturbances, rash, and photosensitivity 1
  • Monitor for rare but serious adverse reactions including Stevens-Johnson syndrome, toxic epidermal necrolysis, and bone marrow suppression 1
  • Regular monitoring of complete blood count is recommended for prolonged therapy 1

Treatment Alternatives

  • For patients who cannot tolerate TMP-SMX or in cases of resistance, alternative options include:
    • Clindamycin (300-450 mg orally three times daily) 1
    • Doxycycline (100 mg twice daily) 1
    • Minocycline (200 mg initially, then 100 mg twice daily) 1
    • Linezolid (600 mg twice daily) - reserved for severe cases due to cost 1

Important Clinical Pearls

  • Incision and drainage should be performed for any follicular abscess formation 1
  • Consider obtaining cultures in cases of recurrent or treatment-resistant folliculitis 2
  • For recurrent folliculitis, consider a 5-10 day course of an antibiotic active against the identified pathogen 1
  • TMP-SMX can be used concurrently with methotrexate in patients with normal renal function, contrary to previous beliefs about this combination 1

Monitoring

  • Clinical improvement should be evident within 48-72 hours of starting appropriate therapy 1
  • If no improvement is seen after 72 hours, consider alternative diagnoses, resistant organisms, or need for drainage procedure 1, 2
  • For recurrent folliculitis, consider decolonization regimens including intranasal mupirocin and chlorhexidine washes 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Interventions for bacterial folliculitis and boils (furuncles and carbuncles).

The Cochrane database of systematic reviews, 2021

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.